Dna X (SONM) Share-based Compensation (2018 - 2026)

Dna X (SONM) has 9 years of Share-based Compensation data on file, last reported at $541000.0 in Q1 2026.

• Quarterly Share-based Compensation rose 26950.0% year-over-year to $541000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $541000.0 (down 55.03% YoY) and the FY2025 annual result came in at $1.5 million, up 1.05% from the prior year.
• Share-based Compensation climbed to $541000.0 in Q1 2026, from $159000.0 in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $1.2 million in Q4 2023 to a low of $2000.0 in Q1 2025.
• A 5-year average of $460647.1 and a median of $358000.0 in 2023 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2025 — Share-based Compensation plunged 99.38% — and 2026, when it soared 26950.0%.
• Tracing SONM's Share-based Compensation over 5 years: stood at $1.0 million in 2022, then grew by 10.99% to $1.2 million in 2023, then slumped by 69.07% to $356000.0 in 2024, then tumbled by 55.34% to $159000.0 in 2025, then surged by 240.25% to $541000.0 in 2026.
• The last three Share-based Compensation figures came in at $541000.0 (Q1 2026), $159000.0 (Q4 2025), and $692000.0 (Q3 2025), per Business Quant data.